Related by context. All words. (Click for frequent words.) 68 WOMAC pain 67 ejaculatory function 67 Symptom severity 67 NIH CPSI 67 HRQoL 67 Female Sexual Function 66 Cardiorespiratory fitness 66 serum lipid levels 65 Index FSFI 65 serum testosterone 65 bioavailable testosterone 64 HRQOL 64 EQ 5D 64 Zestra R 64 ALISTA 64 tumor histology 64 Distress Scale 64 EORTC QLQ C# 63 lipid elevations 63 HRQL 63 comorbid anxiety 63 LUTS 63 hypogonadal 63 Index CDAI 63 GH deficiency 63 SSRI SNRI 63 certolizumab 63 CORE OM 63 urodynamic 63 analgesic efficacy 62 subscale scores 62 HAM D# 62 intact parathyroid hormone 62 PCWP 62 symptom severity 62 Secondary endpoints include 62 corticosteroid dose 62 hematological parameters 62 dietary calcium intake 62 PSA nadir 62 BMI z 62 IIEF 62 IELT 62 Primary endpoints 62 Secondary efficacy endpoints 62 convergent validity 62 thyrotropin 62 MoxDuo TM IR 62 psychometric properties 62 liver histology 62 Comorbidity 62 DAS# scores 62 dyspareunia 62 serum bicarbonate 62 Crohn Disease Activity 62 transdermal testosterone 62 Brief Psychiatric 62 DAS# CRP 62 plasma leptin 61 ADCS CGIC 61 reactogenicity 61 urinary N telopeptide 61 interobserver 61 depressive symptomatology 61 SGRQ 61 psychiatric comorbidities 61 serum concentrations 61 histological subtype 61 ejaculatory control 61 urinary cortisol 61 N telopeptide 61 Inventory BPI 61 elevated ALT 61 histologic subtype 61 multivariate analyzes 61 cognitive affective 61 intratympanic 61 Zoraxel 61 hypogonadal men 61 μg liter 61 antibody titer 61 dyslipidaemia 61 epoetin alpha 61 neurocognitive function 61 attain statistical significance 61 opioid naïve 61 thyrotropin levels 61 erectile dysfunction impotence 61 oral prednisolone 61 CIN2 + 61 salivary cortisol 61 Atomoxetine 61 abdominal adiposity 61 alfuzosin 61 rhGH 61 Erectile Function IIEF 61 hip BMD 60 HOMA IR 60 intravaginal ejaculatory latency 60 prolactin levels 60 genital arousal 60 urinary albumin excretion 60 prasterone 60 prospectively stratified 60 clomipramine 60 overactive bladder symptoms 60 Neuropsychiatric Inventory 60 hormone binding globulin 60 Erectile function 60 Visual Analogue Scale VAS 60 bladder bowel 60 desvenlafaxine succinate 60 clinicopathological features 60 pituitary hormone 60 Fibromyalgia Impact Questionnaire 60 albumin excretion rate 60 albumin excretion 60 guideline concordant 60 meta regression 60 colorectal adenoma 60 venlafaxine XR 60 urinary bowel 60 pharmacokinetic PK profile 60 oxycodone CR 60 Sociodemographic 60 Heritability 60 Generic Viagra Soft Tabs 60 antiarrhythmic drug 60 #OHD 60 SSRI citalopram 60 NNT = 60 mean ± SEM 60 interrater 60 CPAP adherence 60 preoperative PSA 60 intraclass correlation coefficients 60 anogenital distance 60 CIMZIA ™ 60 HIV HCV coinfected 60 penile vaginal intercourse 60 relapsed MM 60 BEXXAR Therapeutic Regimen 60 interrater reliability 60 affective psychoses 60 serum bilirubin 60 PANSS scores 60 GH deficient 60 triiodothyronine 60 serum PTH 60 pharmacodynamic parameters 60 VigRX Plus 60 urolithiasis 60 LDL HDL 60 HAMD 60 visceral adiposity 60 neuropsychological functioning 60 serum estradiol 60 MMSE score 60 haematologic 60 trospium 60 CRp 60 Skin sterol 60 HER2 expression 60 clinically meaningful improvement 60 Yohimbine 60 posttreatment 60 glycosylated hemoglobin HbA1c 60 multiple logistic regression 60 Bioavailability 60 Erectile Function 60 diabetes mellitus DM 60 Mg Uk 60 recurrent venous thromboembolism 60 pramlintide metreleptin combination 60 inotropes 59 postoperative AF 59 SF #v# 59 anthropometric measures 59 paroxetine sertraline 59 urodynamic parameters 59 serum IGF 59 eNO 59 morphometric vertebral fractures 59 hypogonadotropic hypogonadism 59 Hypoactive Sexual Desire Disorder 59 autonomic dysfunction 59 psychosocial functioning 59 Insulin sensitivity 59 exhaled nitric oxide 59 elevated creatinine 59 hMG 59 Scale PANSS 59 AST ALT 59 serum lipid 59 serum urate levels 59 Effexor venlafaxine 59 Ashworth Scale 59 YMRS 59 % CI #.#-#.# [008] 59 vasomotor 59 elevated transaminases 59 Erectile 59 Neuropsychiatric Inventory NPI 59 serum cortisol 59 MetS 59 plus medroxyprogesterone acetate 59 Androgens 59 clinicopathological 59 EBRT 59 prednisone prednisolone plus 59 QoL 59 clinico pathological 59 alicaforsen enema 59 multivariate Cox 59 biologic DMARD 59 intraobserver 59 rFSH 59 pulse amplitude 59 somatostatin analog 59 logistic regression analyzes 59 HADS 59 demonstrated clinically meaningful 59 Y BOCS 59 ORTHO EVRA R 59 SELENA SLEDAI 59 pharmacokinetic characteristics 59 diovan 59 tissue oxygenation 59 HAQ DI 59 BPS IC 59 glucocorticoid induced 59 antioxidant supplementation 59 Heavy menstrual bleeding 59 carotid IMT 59 conditional logistic regression 59 serum cotinine 59 neurocognitive functioning 59 Pharmacologic 59 intraclass correlation coefficient 59 System IPSS 59 tumorigenicity 59 acromegalic patients 59 Secondary endpoints 59 erythrocyte sedimentation rate 59 aspartate aminotransferase AST 59 Severity Index PASI 59 QIDS SR 59 Symptom Checklist 59 apolipoproteins 59 T1DM 59 Montgomery Asberg Depression 59 non menstrual pelvic 59 sociodemographic characteristics 59 Preoperatively 59 psychiatric comorbidity 59 Reynolds Risk Score 59 anthropometric measurements 59 triglyceride concentrations 59 BARACLUDE r 59 secondary efficacy endpoint 59 glycosylated hemoglobin levels 59 chronic prostatitis 59 Fasting plasma glucose 59 airway responsiveness 59 BENICAR HCT 59 Histologic 59 DAS# remission 59 serum ferritin 59 Multiple logistic regression 59 oncologic outcomes 59 DLQI 59 mucosal inflammation 59 titrated glipizide 59 Montgomery Åsberg Depression 58 Multivariate logistic regression 58 serum testosterone levels 58 pyridostigmine 58 aminotransferases 58 UPDRS motor 58 antiepileptics 58 echocardiographic parameters 58 urinary symptoms 58 Likert scale 58 treat premature ejaculation 58 #q# deletion syndrome 58 eosinophil count 58 aminotransferase 58 CIMZIA TM certolizumab pegol 58 antimuscarinic 58 confidence intervals CIs 58 exploratory endpoints 58 SGPT 58 maintain penile erection 58 depressive symptom 58 Non inferiority 58 transabdominal 58 HDRS 58 inotropic 58 serum GGT 58 fluoxetine paroxetine 58 premorbid 58 serum folate concentrations 58 posttest 58 oral diclofenac 58 NATRECOR ® 58 serum IgE 58 PANSS 58 cervicitis 58 dose proportionality 58 pre pubertal 58 WOMAC scores 58 lipid profiles 58 Edinburgh Postnatal Depression 58 venous thromboembolic disease 58 prospectively defined 58 efficacy tolerability 58 body fatness 58 conjugated equine estrogen 58 alanine aminotransferase 58 dose Iluvien 58 Catheter Associated 58 shorter telomere length 58 tolterodine ER 58 affective psychosis 58 percutaneous vertebroplasty 58 psychopathological symptoms 58 Global Impression CGI 58 serum leptin 58 nasal symptom 58 FeNO 58 inhaled corticosteroid therapy 58 pCR 58 antiandrogens 58 baseline Hb 58 neutropaenia 58 STRIDE PD 58 subscore 58 tertile 58 hormone estradiol 58 pegylated IFN 58 overactive bladder syndrome 58 methacholine challenge 58 daytime alertness 58 anti Mullerian hormone 58 highest tertile 58 hypertension diabetes mellitus 58 CC genotype 58 CR nPR 58 COMT genotype 58 plasma lipid 58 tipranavir r 58 serum parathyroid hormone 58 tertiles 58 % CI #.#-#.# [004] 58 somatic symptoms 58 Health Assessment Questionnaire 58 Breslow thickness 58 covariate 58 thromboembolic disease 58 Nocturia 58 psychiatric morbidity 58 cardiac repolarization 58 methylphenidate MPH 58 thyroid peroxidase 58 salmeterol fluticasone propionate 58 tonsillar hypertrophy 58 gastric cardia 58 intima media thickness 58 metaanalysis 58 tryptase 58 homocysteine concentrations 58 A1c levels 58 plasma folate 58 tibolone 58 phosphodiesterase inhibitors 58 carotid stenosis 58 Clinical Practice Guideline 58 left ventricular diastolic 58 Androgel R 58 systemic hypotension 58 Poisson regression 58 se xual 58 premenstrual syndrome PMS 58 baseline LDH 58 posttransplant 58 angiographically 58 endometrial thickness 58 fasting plasma 58 WOMAC 58 FSFI 58 androgenic 58 chlamydial infection 58 urinary cadmium 58 hemodynamic measurements 58 HbA1C levels 58 follicular phase 58 lipid parameters 58 antitrypsin 58 PHQ 9 58 bone metabolism 58 transferrin saturation 58 Cronbach alpha 58 analgesic medications 58 Viagra Sildenafil 58 ß blockers 58 platelet inhibition 58 artery stenosis 58 parous women 58 Akathisia 58 cerebral oxygenation 58 erythropoietic 58 IM progesterone 58 adrenal function 58 nitroprusside 58 lipid lowering agents 58 menopause contraception 58 CYP#D# inhibitor 58 Score DAS 58 comorbid depression 58 plasma cortisol 58 CDAI score 58 Depressive symptoms 58 NIHSS score 58 unconjugated 58 PASI scores 58 NOAEL 58 glycated hemoglobin HbA1c 58 adenotonsillectomy 58 Coronary artery bypass grafting 57 fructosamine 57 transaminase elevations 57 hemodynamic parameters 57 CFQ R 57 Socioeconomic status 57 pain palliation 57 postmenopausal osteoporotic women 57 sensitivity specificity 57 urothelial carcinoma 57 Psoriasis Area 57 serum CRP 57 serum homocysteine 57 subscales 57 dyspnoea 57 prospective multicentre 57 undetectable HBV DNA 57 #ß 57 Main Outcome Measure 57 % Confidence Interval 57 transrectal ultrasound guided 57 CONCERTA ® 57 CYP#D# genotype 57 cardio metabolic 57 baseline HbA1c 57 multivariable adjusted 57 Brief Pain 57 neurosensory 57 tipranavir ritonavir 57 ACR# ACR# 57 symptomatic DVT 57 serum phosphate 57 alanine aminotransferase ALT 57 zoledronate 57 antidiabetic drugs 57 Testosterone deficiency 57 corpus cavernosum 57 phosphodiesterase inhibitor 57 euthymic 57 somatoform disorders 57 % CI #.#-#.# [005] 57 pretransplant 57 dosage regimens 57 LH FSH 57 mu opioid 57 tumor subtype 57 sUA 57 cranial irradiation 57 arterial elasticity 57 adenoma recurrence 57 sexual dysfunctions 57 tapentadol IR 57 waist circumference WC 57 interobserver reliability 57 pharmacodynamic PD 57 brachial artery flow 57 mild renal insufficiency 57 serum urate 57 multivariable logistic regression 57 adjunctive ABILIFY 57 buprenorphine implants 57 alexithymia 57 pain catastrophizing 57 premenstrual dysphoric disorder 57 ADAS cog 57 comorbid disorders 57 serotonin norepinephrine 57 serum HBV DNA 57 BPH LUTS 57 bivariate analyzes 57 Negative Symptoms 57 sacral nerve stimulation 57 differential gene expression 57 NYHA functional class 57 hematopoietic cancers 57 hemoglobin A1c HbA1c 57 Outcome Measures 57 nonpharmacologic 57 salivary flow 57 lowest tertile 57 preoperative diagnosis 57 REMINYL ® 57 Hazard Ratio HR 57 abnormal cytology 57 inflammatory biomarkers 57 bronchial hyperresponsiveness 57 VTE prophylaxis 57 metabolite concentrations 57 subscores 57 allergic airway inflammation 57 nonfasting triglyceride levels 57 Pharmacodynamics 57 â ‰ ¥ 57 pharmacokinetic parameters 57 biochemical recurrence 57 postprandial glycemia 57 metabolic parameters 57 CP CPPS 57 = #.#-#.# 57 prognostic indicators 57 PHPT 57 ALT flares 57 systolic diastolic 57 prognostic variables 57 Randomized controlled 57 antiangiogenic therapy 57 urine albumin 57 DEXA scan 57 Rating Scale MADRS 57 adiponectin concentrations 57 Sumatriptan OS 57 adrenal suppression 57 FACIT 57 EDEMA3 trial 57 plasma pharmacokinetics 57 serum PSA 57 PON1 activity 57 HbA1C 57 clevidipine 57 sociodemographic variables 57 glycaemia 57 gp# vaccine 57 phthalate metabolites 57 daytime somnolence 57 NMDA antagonists 57 antiemetics 57 virological response 57 Prelox 57 Child Behavior Checklist 57 See CLINICAL PHARMACOLOGY 57 Female Sexual Dysfunction 57 Peyronie Disease 57 MSLT 57 dimeglumine 57 Prolactin 57 pharmacological therapy 57 oral antidiabetic medication 57 anogenital 57 Lower Limb 57 aspirin NSAIDs 57 avanafil PDE5 inhibitor 57 chronic prostatitis chronic 57 aldosterone antagonist 57 diastolic pressures 57 LAB CGRP 57 unprotected receptive anal 57 antiandrogen 57 multivariable analyzes 57 comorbid psychiatric disorders 57 daily subcutaneous injections 57 Secondary endpoints included 57 pulmonary capillary wedge 57 catheter ablations 57 serum retinol 57 Functional Assessment 57 neurodevelopmental outcome 57 Transdermal Delivery 57 hypercalciuria 57 systemic corticosteroid 57 Tumor Response 57 generalisability 57 thromboprophylaxis 57 serum prostate 57 mesalamine granules 57 dose atorvastatin 57 hemostatic efficacy 57 treat benign prostatic 57 penile erection 57 ANCOVA 57 MADRS score 57 gp# protein [002] 57 Main Outcome Measures 57 pharmacokinetics PK 57 cardiac autonomic 57 atrioventricular block 57 prostaglandin E1 57 aspartate aminotransferase 57 nonmetastatic prostate cancer 57 Sexual dysfunction 57 atypical antipsychotic medications 57 leukocyte count 57 Fasting glucose 57 atherogenic dyslipidemia 57 moderate hepatic impairment 57 guanfacine extended release 57 teriflunomide 57 glomerular filtration 57 PsA 57 extensive metabolizers 57 p = #.# [003] 57 prospective multicenter study 57 DAS# [002] 57 virologic responses 57 antiplatelet medications 57 Ziprasidone 57 inotropic agents 57 pegylated alpha interferon 57 conivaptan 57 serum uric acid 57 HIV seronegative 57 Hamilton Anxiety Scale 57 hepatic enzyme 57 RE LY ® 57 salmeterol fluticasone 57 PDE5 inhibitor 57 cystoscopic 57 riociguat 57 International Prostate Symptom 57 Estrogen Receptor 57 mRS 57 comorbid psychiatric 57 glycated hemoglobin levels 57 alteplase 56 leukocyte counts 56 lactate dehydrogenase 56 ARB telmisartan 56 voiding dysfunction 56 multivariate logistic regression 56 hepatic lesions 56 Bacterial vaginosis 56 abnormal lipid 56 ng dL 56 nicardipine 56 MAS XR 56 probiotic supplementation 56 menopausal symptom 56 perioperatively 56 corrected QT interval 56 isoprostane 56 IBDQ 56 MAGE A3 ASCI 56 GI toxicity 56 oocytes retrieved 56 Psychosocial interventions 56 dehydroepiandrosterone sulfate 56 oestradiol 56 internalizing disorders 56 mecamylamine 56 vaginal lubrication 56 inflatable penile prosthesis 56 Logistic regression 56 serum TSH 56 Calcium intake 56 Benign Prostatic Hyperplasia 56 F FDG PET 56 Incontinence Impact Questionnaire 56 CINQUIL 56 CHADS2 56 univariate analyzes 56 β blocker 56 TWYNSTA 56 macrolide antibiotic 56 adrenocortical 56 Atkins dieters cardiovascular 56 behavioral disinhibition 56 FFNS 56 hsCRP levels 56 postmenopausal estrogen 56 intracranial hemorrhage ICH 56 Outcomes Study 56 duplex ultrasonography 56 prucalopride 56 Coronary CTA 56 Tasigna prolongs 56 LAGB 56 nmol l 56 urinary tract symptoms 56 CCyR 56 neutrophil counts 56 mcg ml 56 Neuroticism 56 tic severity 56 #dhTxB# 56 trials RCTs 56 HIV uninfected 56 Meta analyzes 56 Kleinplatz 56 chemosensitivity 56 Cardiotoxicity 56 micronized progesterone 56 endometriosis ovarian cysts 56 C telopeptide 56 androgen suppression 56 SHBG levels 56 Lp lipoprotein 56 IOP lowering 56 symptomatic VTE 56 haematological 56 retrospective observational study 56 melphalan prednisone 56 functional gastrointestinal disorders 56 endoscopic remission 56 abacavir lamivudine 56 Radical prostatectomy 56 specific antigen PSA 56 FluCAM arm 56 serum ALT 56 headache abdominal pain 56 hyperphenylalaninemia HPA due 56 hyperalgesia 56 4mg/kg 56 hypercholesterolaemia 56 nerve conduction velocity 56 hydroxyvitamin D levels 56 p = .# [002] 56 Chlamydia trachomatis infection 56 BPH symptom 56 Trinovin 56 psychosocial variables 56 GH IGF 56 pretreatment serum 56 APTIVUS r 56 electrophysiologic 56 dietary folate 56 logistic regression model 56 EEG abnormalities 56 peak plasma concentrations 56 mm Hg diastolic 56 Q#IR 56 HbA 1c levels 56 complete cytogenetic response 56 sociodemographic factors 56 Score TOS 56 prostaglandin analogues 56 polytherapy 56 pre operatively 56 Prostate specific antigen 56 thrombocytopenic 56 nodal metastasis 56 residual platelet reactivity 56 indications contraindications 56 receptive anal sex 56 disorder FSAD 56 androgenic hormones 56 MADRS 56 phenelzine 56 HIV coinfected 56 cobalamin 56 aminotransferase levels 56 Premature ejaculation 56 arteries dilate 56 randomized controlled trials RCTs 56 lipoprotein levels 56 hormones progesterone 56 oxcarbazepine 56 Tibolone 56 prenatal exposures 56 affective disorders 56 Warfarin Coumadin 56 MCID 56 Vimax Pills 56 torsemide ER 56 euthymic patients 56 vardenafil Levitra 56 HBsAg 56 PLX STROKE targeting 56 hormone androgen 56 Selective serotonin reuptake inhibitors 56 Disease Activity 56 solifenacin 56 total cholesterol triglycerides 56 adjunctive placebo 56 Pharmacokinetic parameters 56 interpersonal psychotherapy IPT 56 anticholinergic agents 56 pulmonary artery banding 56 Visual Analog Scale 56 divalproex sodium 56 erectile function 56 antitumor effect 56 HBsAg positive 56 antidepressant pharmacotherapy 56 non fasting triglycerides 56 SCr 56 IntroductionThe 56 postoperative complication 56 RAPAFLO R 56 sonographically guided 56 apolipoprotein B 56 ritonavir boosted 56 viral kinetics 56 LB# [003] 56 Retreatment 56 sensory gating 56 thorough QT 56 vesicoureteral reflux 56 Attention-Deficit/Hyperactivity Disorder ADHD 56 Visual Analog 56 irregular menses 56 seropositivity 56 hormone receptor status 56 Pharmacodynamic 56 intradermal injections 56 Dietary intakes 56 serum calcium 56 Endothelial function 56 SSc 56 abnormal ejaculation 56 nonobese 56 GnRH agonist 56 Serum calcium 56 urodynamic studies 56 Bosentan 56 perimenopausal women 56 constipation OIC 56 RAPAFLO TM 56 ERalpha 56 immunotoxicity 56 Sexual Satisfaction 56 deep venous thromboses 56 pelvic lymphadenectomy 56 APTIVUS R 56 urethral stricture 56 FXIII 56 SCIg 56 HMG CoA reductase inhibitors 56 ProSolution Pills 56 sacral neuromodulation 56 primary dysmenorrhoea 56 longitudinal observational study 56 lymphocyte count 56 dentin hypersensitivity 56 x ULN 56 multiple linear regression 56 permanently discontinue Vectibix 56 Alzheimer Disease Assessment 56 Lofexidine 56 Captopril 56 Eur Urol 56 Nonspecific 56 cefepime 56 micafungin 56 microvessel 56 anticholinergic medication 56 cirrhotic patients 56 interpersonal psychotherapy 56 serum lipids 56 Univariate analysis 56 microbiologically evaluable 56 peak VO2 56 ACR Pedi 56 emotional lability 56 serum phosphorous 56 euthyroid 56 Angiotensin converting enzyme 56 aldosterone antagonists 56 anagrelide 56 prepubertal 56 dosing frequency 56 topical NSAIDs 56 REYATAZ r arm 56 perinatal outcomes 56 haemodynamic 56 multivariable analysis 56 retrograde ejaculation 56 NIHSS 56 intravenous cyclophosphamide 56 QTc intervals 56 hematologic toxicity 56 serum vitamin D 56 radiotherapy RT 56 spirometric 56 QALE 56 BoNTA 56 cinacalcet 56 LYSTEDA 56 mg Pycnogenol 56 NMES 56 hydroxy vitamin D 56 sub maximal 56 urinary excretion 56 Zevalin consolidation 56 Retrograde ejaculation 56 #q# deletion 56 colonoscopic 56 Carvedilol 56 dorzolamide 56 CNS LS 56 nulliparous women 56 FDG uptake 56 immunosuppression therapy 56 onset diabetes mellitus 56 ACTEMRA TM 56 pT3 56 H2RAs 56 Growth Hormone Deficiency 56 orofacial clefts 56 cardiometabolic risk 56 intracellular uptake 56 pentoxifylline 56 Fecal Incontinence 56 postoperative mortality 56 APOE genotype 56 clinicopathologic 56 psychiatric outpatients 56 etiologic 56 thromboembolic complications 56 LNG IUS 56 Ocular Surface Disease 56 PSQI 56 Venous thromboembolism 56 dysfunctional voiding 56 HbA 1c 56 insulin detemir 56 K DOQI 56 metronidazole gel 56 PLMs 55 ADCS ADL 55 LHRH agonists 55 mutated K ras 55 phytoestrogen intake 55 biopsy Gleason 55 psychophysiological 55 logistic regression analysis 55 symptomatic intracranial hemorrhage 55 anemia hemoglobin 55 β blockers 55 platelet reactivity 55 urothelial 55 lactate dehydrogenase LDH 55 Cystatin C 55 pharmacodynamics PD 55 glucocorticoid induced osteoporosis 55 Repeatability 55 subclinical atherosclerosis 55 induced sputum 55 pharmacodynamic properties 55 testicular tumors 55 neuropsychological assessment 55 QT QTc 55 effector function 55 Visual acuity 55 HER2 overexpression 55 Subgroup analysis 55 comparator arm 55 oral antidiabetes 55 postoperative radiotherapy 55 penile curvature 55 umol L 55 platelet activation 55 seroprotective 55 Androxal TM 55 pulmonary artery hypertension 55 paricalcitol 55 AGHD 55 Rating Scale BPRS 55 procedural sedation 55 Ophena TM 55 Socio demographic 55 International Prognostic Scoring 55 Androgen 55 preterm neonates 55 Inhibin B 55 improves glycemic 55 tranylcypromine 55 Suboptimal 55 endothelin antagonists 55 placebo controlled dose escalation 55 opioid dependent 55 transurethral 55 NPH insulin 55 hypothalamic pituitary adrenal axis 55 Lovaza ® 55 pharmacodynamic endpoints 55 detrusor 55 serologically active patients 55 premenopause 55 Testosterone MDTS R 55 Zestra TM 55 inhibin B 55 MAXALT